Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 7%.
- Date of event: 18 Dec 2025.
PERCEPTIVE ADVISORS LLC - 18 Dec 2025 SCHEDULE 13G Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- TENX
- Shares outstanding
- 6,273,457 shares
- Disclosed Ownership
- 439,142 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Dec 2025, 16:30:02 UTC
- Date of event
- 18 Dec 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 7% ownership in Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX) on 18 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Dec 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 7% | 439,142 | 0 | 439,142 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 7% | 439,142 | 0 | 439,142 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 7% | 439,142 | 0 | 439,142 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |